3-邻氯苯基-3-(5,5二甲基-3-羟基-2-环己烯-1-酮-2-基)丙酸乙酯的合成和晶体结构

标题化合物C19H23O4Cl（4）是由邻氯苯甲醛（1）与5，5-二甲基-1，3-环己二酮（2）、2，2-二甲基-1，3-二氧六环-4，6-二酮（3）在乙醇中反应而得。结构通过单晶X-射线衍射分析确定，其晶体属于单斜晶系，空间群晶体结构用直接法解出，使用全矩阵最小二乘法对原子参数进行修正，最后的偏离因子R＝0．034，Rw＝0．042。在晶体结构中存在一个共轭的烯醇结构。单晶X-射线分析表明；平面1（C（1）～C（6）、Cl）和平面2（C（8）～C（10）、C（12）、C（13））之间的两面角为97．11°，原子C（7）呈变形的四面体构型。     

3,3-二甲基-9-(5,5-二甲基-3-羟基-2-环己烯-1-酮-2-基)-1-氧代-2,3,4,9-四氢化氧杂蒽的合成和晶体结构

标题化合物C23H26O4是由水杨醛与5，5-二甲基-1，3-环己二酮在N，N-二甲基甲酰胺中反应而得．结构通过单晶X-射线行射法确定，其晶体属于单料晶系，空间群P21/c，a=7．056（7），b=20.263（3），c=13．665（2）A，β＝93．32（1）°，V=1950．7（4）A3，Mr=366．46，Dc=1.248g／cm3，Z=4，μ（MoKa）=0．84cm－1，F（000）=784。晶体结构用直接法解出，经全矩阵最小二乘法对原子参数进行修正，最后的偏离因子R=0．068，Rw=0．075。晶体结构分析结果表明，分子中存在一个共轭的烯醇式结构。     

3,3,6,6-四甲基-4a-羟基-9-邻甲氧基苯基-1,8-二氧代-2,3,4,4a,5,6,7,8,9,9a-十氢化-1H-氧杂蒽的合成和晶体结构

标题化合物C24H30O5是由邻甲氧基苯甲醛与5，5-二甲基-1，3-环己二酮在N，N-二甲基甲酰胺中反应而得。结构通过单晶X-射线衍射法确定，其晶体属于单斜晶系，空间群C2／c，a=33．942（6），b=7273（1），c=22667（4）A，β=128．989（9）°，Mr=398．50，V=4349（1）A3，Dc=1．2179·cm-3，Z=8，μ（MoKa）=840mm－1，F（000）=1712。晶体结构用直接法解出，经用全矩阵最小二乘法对原子参数进行修正，最后的偏离因子为R=0.043，Rw=0．052。在晶体结构中，存在一个分子间氢键。     

亚甲基烯酮与5-亚甲基-1,3-二噁烷-4,6-二酮反应机理的研究

利用半经验分子轨道理论AM1方法，研究了5-亚甲基-1，3-二噁烷-4，6-二酮与亚甲基烯酮的2，3-位C＝C，3，4-位C＝O和1，2-位C＝O三种双键位置上的环加成反应的反应机理．采用Berny梯度法优化得到反应的过渡态，并进行了振动分析确认．计算结果表明，环加成反应是按照协同的非同步途径进行的，经过一个扭曲的六员环过渡态，前线轨道分析表明反应机理为［4＋2］机理．根据AM1优化得到的产物反应物及过渡态的生成热可知三个反应的活化焓分别为27．07kJ·mol-1，32．41kJ·mol-1和137．96kJ·mol-1，2，3-位C＝C双键上的环加成反应的活化焓最低，这与实验中只观察到2，3－位C＝C双键上环加成产物的结论是一致的．     

5-苯基-3,5-二乙氧基-2(5H)-呋喃酮的晶体结构

标题化合物C14H16O4的晶体结构用X-射线单晶衍射法测定。晶体属三斜晶系,P空间群,晶胞参数a =8.696(2), b=8.943(2) , c=9.379(2) ?, ( = 69.28(3), ( =76.67(3), ( =80.28(3)o, V=660.8(3) ? 3, Z=2, Mr=248.28, Dx=1.248 g/cm3, F(000)=264, μ(MoK()=0.0851 mm—1。晶体结构用直接法解出,经全矩阵最小二乘法对原子参数进行修正,最终的偏离因子为R=0.061, wR=0.089。标题化合物有2个环：呋喃酮环和苯环。由C(1),C(2),C(3),C(4),O(4)构成的五元呋喃酮环的5个原子较好地处于1个平面上,平均偏差为0.0078?。O(2),O(3) 两个原子与呋喃酮环共平面。呋喃酮环和苯环之间的两面角为79.39o。     

2-(5-甲基-1，3，4-噻二唑)-硫乙酸稀土配合物的合成和晶体结构

由溶液法合成了2个稀土配合物{[Ln(Hmtyaa)3(H2O)2].H2O}n(Ln=Nd,1;Pr,2)(Hmtyaa=2-(5-甲基-1,3,4-噻二唑)-硫乙酸),用X-射线单晶衍射仪测定了配合物的单晶结构,并对其进行了元素分析、红外光谱、热重和粉末X-射线衍射等表征。晶体结构表明:配合物1和2结构相同,都属于三斜晶系,P1空间群。配合物中金属离子均采取九配位模式,金属离子被配体桥连形成一维双链结构,该一维双链被氢键和π-π作用连接成二维层状结构。     

2,6-二甲基-3-苯基-4a-对甲苯基-7-苯甲酰基-4a,5,6,12-四氢-1H,7H-1,3-噁嗪并[3,2-d][1,5]-苯并二氮杂-1-酮的合成及晶体结构

通过2-甲基-4-对甲苯基-1-苯甲酰基-2，3-二氢-1H－1，5-苯并二氮杂与由不对称1-苯基-2-偶氮-1，3-丁二酮热解产生的a-羰基烯酮的[2＋4]环加成反应制备了标题化合物（C34H30N2O3，Mr=514．62），用X射线衍射测定了其单晶结构。晶体属单斜晶系，空间群为P21／n，a=11．560（1），b=19．058（3），c=13．207（2）A，β=106.82（1）°，V=2785.2（7）A3，Z=4，Dc=1．230g．cm-3，MoKa（λ=0.71073A），μ=0．064mm-1，F（000）=1088，2278个可观测衍子射点，R=0．046，Rw=0．049。分子骨架为由苯环、具有类扭船式构象的七元二氮杂环和略微扭曲的唑酮环构成的三环体系。     

六(3,3-二甲基-1-(1H-1,2,4-三唑)-2-丁酮)锌高氯酸盐配合物的合成及晶体结构

3，3-二甲基-1－（1H－1，2，4-三唑）－2-丁酮的锌配合物（C48H78Cl2N18O14Zn）已被合成。X-射线衍射结构分析表明，晶体属单斜晶系，空间群P21／n，晶体学数据：晶体体积结构偏离因子，标题配合物分子中6个三唑环上的4位N原子与Zn原子配位，形成八面体结构，锌原子处在结晶学的对称中心上。     

锑(Ⅲ)-2-(3,5-二溴-2-吡啶偶氮)-5-二乙胺基酚-溴代十六烷基三甲胺的络合物吸附波

在pH5.3的HAc－NaAc、2－（3，5－二溴－2－吡啶偶氮）－5－二乙氨基酚（3，5－Br2－PADAP）、溴代十六烷基三甲铵（CTMAB）溶液中，用线性扫描示波极谱法可得到锑（Ⅲ）的络合物吸附波。峰电位为－0.70V（vs．SCE）。二阶导数档峰高与Sb（Ⅲ）浓度在3．3X10-8～2．5X10－6mol／L范围内呈线性关系。检出限为8．2X10-9mol／L。用多种电化学方法研究了极谱波的性质及电极反应机理。络合物组成为Sb（Ⅲ）：3，5－Br2－PADAP＝1∶2。加入CTMAB可消除试剂峰且提高灵敏度。试验了30多种离子对峰电流的影响，用流基棉分离干扰离子。方法已用于矿样中锑的测定。     

离子液体(1-甲基-3-羧甲基咪唑)钴配合物的合成和晶体结构

由离子液体1-甲基-3-羧甲基咪唑硫酸氢盐([C6H9N2O2][HSO4])和氯化钴合成了一种新的配合物[Co(H2O)4(C6H8N2O2)2]Cl2.2H2O;采用单晶X射线衍射方法测定了配合物的晶体结构.结果表明,所合成的配合物C12H28Cl2CoN4O10属于三斜晶系,空间群P-1,a=0.66753(5)nm,b=0.91751(6)nm,c=1.80604(13)nm,α=85.618(5)°,β=83.385(5)°,γ=83.443(5)°,V=1.08934(13)nm3,Z=2,Mr=520.23,F(000)=538,Dc=1.580g.cm-3,μ(Mo-Kα)=1.088mm-1,R1=0.0861,wR2=0.2878.单晶X射线分析结果表明,在所合成的配合物中,每个1-甲基-3-羧甲基咪唑除羧基外其它原子均位于同一平面,咪唑环带正电荷,而羧基氢原子消失;即整个1-甲基-3-羧甲基咪唑分子不带电荷.总体而言,配合物的内界[Co(H2O)4(C6H8N2O2)2]2+带两个正电荷,外界游离的两个氯离子起平衡电荷作用.     

Synthesis,Spectroscopic Properties and Crystal Structural Characterization of a Triphenyltin(IV) Complex with 5-Bromonicotinic Acid

1 INTRODUCTION Organotin esters of carboxylic acids are widely used as biocides, fungicides and homogeneous ca- talysts in industry[1～3]. Recently, pharmaceutical pro- perties of organotin esters of carboxylic acids have been investigated for their antitumour activity[4, 5]. Studies on organotin compounds containing car- boxylate ligands with additional donor atoms (e.g. N, O or S) that are available for coordination to the tin atom have revealed that new structural types may lead to di…     

Synthesis and Crystal Structure of (Z)-Ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxypheny-tetrahydrofuran-3,3-dicarboxylate

The title compound (Z)-ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxyphenyl)- tetrahydrofuran-3,3-dicarboxylate has been synthesized, and its crystal structure was characterized by X-ray single-crystal diffraction. The crystal belongs to triclinic, space group P1-, with a = 8.140(3), b = 11.966(4), c = 13.771(5) α = 67.366(4), β = 85.165(5), γ = 75.806(4)°, V = 1200.1(7) 3, Z = 2, C26H30O8, Mr = 470.50, Dc = 1.302 g/cm3, F(000) = 500, λ(MoKα) = 0.71073 , μ = 0.096 mm–1, R = 0.0659 and wR = 0.1841 for 3080 observed reflections (I > 2σ(I)). As a key intermediate of HIV-1 integrase inhibitor, the synthesis and structure confirmation of the title compound are important for further studies.     

Hydrothermal Synthesis and Crystal Structure of a New 2D Layered Cadmium(II) Coordination Polymer:[Cd(bimc)_2]_n(bimc=1H-Benzimidazole-5-carboxylate)

1 INTRODUCTION Coordination polymers have attracted the atten- tion of chemists, physicists, and materials scientists owing to their fascinating structures and potential functional applications in the last decade[1～4]. The bridging ligands play a central role in constructing functional coordination polymers, and weak nonco- valent interactions like hydrogen bonding or π-π stacking plays an important role in molecular self- assembly[5～7]. As a multidentate and rigid ligand with multi-pr…     

Crystal Structure of 1, 1-Dichloro-la, 3-diphenyl-1, la, 2, 3-tetrahydro-azirino [2, 1-d ] [1, 5]benzothiazepine (C_(22),H_(17)Cl_2NS )

1INTR0DUCTI0NBenzoheteroazepinecompoundsareimportantpharmaceuticalagents"-".Inre-centyears,ithasbeenfoundthatbenzoheter0azepinetricyclicderivatives,especiallythosefusedwithotherfiveorsix-memberedheterocycle,area1soofpotentialphar-maceuticalinterestst4-6j.Hence,muchattentionhasbeenpaidtothesynthesesofthem,suchasl,3-oxazino[3,2-djt1,5jbenzothia/diazepin-l-onet"'J,1,2,4-tria-zolo[4,3-dj[1,5jbenzothia/diazepine"',1,2,4-oxadiazolo[4,5-dj[l,5jbenzothia/diazepine',',andsoon.Meanwhiletheirstructur…     

Synthesis and Crystal Structure of 1-（4-Fluorophenyl）-2-hexylthiobenzo[4,5]-furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5（1H）-one

The crystal structure of the title compound 1-(4-fluorophenyl) -2-hexylthio-benzo [4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a]pyrimidin-5(1H) -one(C23H21FN4O2S,Mr = 436.5) has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic,space group P21/n with a = 13.9854(3) ,b = 17.2678(4) ,c = 18.1828(5) ,β = 99.364(2) °,V = 4332.58(18) 3,Z = 4,Dc = 1.338,F(000) =1824,μ = 0.185 mm-1,MoKa radiation(λ = 0.71073) ,R = 0.0538 and wR = 0.1162 for 4728 observed reflections with I > 2σ(I) . X-ray diffraction analysis reveals the fused rings of benzo[4,5]furo[3,2-d]-1,2,4-triazolo[1,5-a] pyrimidin-5(1H) -one system are nearly coplanar. The crystal packing is mainly stabilized by weak intermolecular C-H···O hydrogen bond and π-π interactions.     

Synthesis and Crystal Structure of 3-（ 2- Hydroxybenzly ）-4-（ 4- Hydro xybenzylideneamino ）-（1H） - 1,2,4- Triazole-5-Thione and Its Antibacterial Activities

1 INTRODUCTION 2. 1 Physical measurements Azole derivatives, such as pyrazole, imidazole, All solvent and chemicals were commercial rea- triazole(including benzotriazole), tetrazole and indole, gents and used without further purification. Ele- have extensive biological activities. They have be- mental analyses were performed on a PE 1700 CHN come the central focus of studies for agricultural che- auto elemental analyzer. IR spectra were recorded on micals, medicines, plant growth regul…     

Synthesis and Crystal Structure of 4-Bromo-5-ethoxy-3-methyl-5- （naphthalen- 1-yl）- 1-tosyl- 1H-pyrrol-2（5H）- one

The title compound 4-bromo-5-ethoxy-3-methyl-5-(naphthalen-1-yl)-1-tosyl-1H- pyrrol-2(5H)-one 1 (C24H22BrNO4S, Mr = 500.40) has been synthesized and its crystal structure was determined by single-crystal X-ray diffraction analysis. It crystallizes in monoclinic, space group P21/n with a = 8.8562(15), b = 18.118(3), c = 14.055(2) , β = 99.855(3)o, V = 2221.9(6) 3, Z = 4, Dc = 1.496 g/cm3, μ = 1.975 mm-1, λ = 0.71073 , F(000) = 1024, R = 0.0607 and wR = 0.1371.     

Crystal Structure of Ethyl 4-benzoyl-1a,2,3,4-tetrahydro-3-methyl-1a-(4-methylphenyl)-1H-azirino〔1,2-a〕〔1,5〕 benzodiazepine-1-carboxylate(C_(28)H_(28)N_2O_3)

１ＩＮＴＲＯＤＵＣＴＩＯＮＢｅｎｚｏｄｉａｚｅｐｉｎｅｃｏｍｐｏｕｎｄｓａｒｅｉｍｐｏｒｔａｎｔｐｈａｒｍａｃｅｕｔｉｃａｌａｇｅｎｔｓ〔１,２〕．Ｒｅｃｅｎｔｌｙｉｔｈａｓｂｅｅｎｆｏｕｎｄｔｈａｔｂｅｎｚｏｄｉａｚｅｐｉｎｅｔｒｉｃｙｃｌｉｃｄｅ...     

Synthesis and Structure of 5-Amino-6-(4-fluorophenylamino)-3-methylthio-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one

The title compound (C18H15FN6OS) has been synthesized and its crystal structure was determined by X-ray analysis. The crystal belongs to monoclinic system, space group P21/n with a = 13.983(10), b = 7.337(5), c = 16.702(12) (A), α = 90, β = 98.277(12), γ = 90°, V = 1696(2)(A)3, Z = 4, Dc= 1.498 g/cm3, Mr = 382.42,μ = 0.224 mm-1, F(000) = 792, the final R = 0.0362 and wR = 0.0878 for 2579 observed reflections with I ＞ 2σ(Ⅰ). In the title compound, the atoms of C(1),C(2), C(3), C(4), C(5), N(1), N(2), N(3), N(4), N(5), N(6), O(1) and S(1) form a fully delocalized system with the average deviation of 0.0307(A). There exists a part of electron delocalization over the planes of Ⅰ (pyrazolo[3,4-d]pyrimidin-4-one moiety), Ⅱ (phenyl moiety) and Ⅲ (p-fluorophenylamine moiety). In the molecule, intermolecular hydrogen bonds between N(6)-H(6)…O(1)and C( 15)-H( 15)…O( 1 ) are observed.